On ECHEMI
Home > Drugs > Heilongjiang Boyu Pharmaceutical Co., Ltd.
Heilongjiang Boyu Pharmaceutical Co., Ltd.
  • Founded in:

    2003-07-09
  • Country:

    China China
  • Address:

    Dongcheng District, Qing'an County, Heilongjiang Province
  • Tax NO.:

    912312247336500198
  • Registered Funds:

    26 million yuan
  • Website:

  • Email:

Related Drugs
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintain normal blood and extracellular fluid volume and osmotic pressure

More

Maintain normal blood and extracellular fluid volume and osmotic pressure

0.85% 7647-14-5 43
Potassium chloride

Replenish potassium ions to maintain body fluid volume and electrolyte balance

More

Replenish potassium ions to maintain body fluid volume and electrolyte balance

0.03% 7447-40-7 38
Calcium chloride

Supplement calcium ions and maintain electrolyte balance

More

Supplement calcium ions and maintain electrolyte balance

0.033% 10043-52-4 27
Metronidazole Sodium Chloride Injection
The main ingredient of this product is: Metronidazole. Its chemical name is: 2-methyl-5-nitroimidazole-1-ethanol. Molecular formula: C6H9N3O3 Molecular weight: 171.16
Name Description Content CAS NO. Registered Holders
Metronidazole

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobic bacteria; it can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa; it has a strong effect in killing trichomonas.

More

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobic bacteria; it can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa; it has a strong effect in killing trichomonas.

443-48-1 39
Tinidazole Sodium Chloride Injection
Tinidazole. Chemical name: 2-methyl-1-[2-(ethylsulfonyl)ethyl]-5-nitro-1H-imidazole.
Name Description Content CAS NO. Registered Holders
Tinidazole

2-Methyl-1-[2-(ethylsulfonyl)ethyl]-5-nitro-1H-imidazole

More

2-Methyl-1-[2-(ethylsulfonyl)ethyl]-5-nitro-1H-imidazole

19387-91-8 12
Ciprofloxacin Lactate Sodium Chloride Injection
The main ingredients of this product are: Ciprofloxacin lactate Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid lactate Molecular formula: C17H18FN3O3C3H6O3 Molecular weight: 421.43
Name Description Content CAS NO. Registered Holders
Ciprofloxacin lactate

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family (including Citrobacter, Enterobacter cloacae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc.). It often also has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase to inhibit DNA synthesis and replication, leading to bacterial death.

More

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family (including Citrobacter, Enterobacter cloacae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc.). It often also has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase to inhibit DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Levofloxacin Lactate Sodium Chloride Injection
Levofloxacin lactate.
Name Description Content CAS NO. Registered Holders
LEVOFLOXACIN LACTATE

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

More

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

294662-18-3 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.